iRhythm Technologies Inc - Asset Resilience Ratio
iRhythm Technologies Inc (IRTC) has an Asset Resilience Ratio of 30.75% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how iRhythm Technologies Inc's Asset Resilience Ratio has changed over time. Check strategic asset allocation of iRhythm Technologies Inc to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down iRhythm Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IRTC stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $309.47 Million | 30.75% |
| Total Liquid Assets | $309.47 Million | 30.75% |
Asset Resilience Insights
- Very High Liquidity: iRhythm Technologies Inc maintains exceptional liquid asset reserves at 30.75% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
iRhythm Technologies Inc Industry Peers by Asset Resilience Ratio
Compare iRhythm Technologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM |
Medical Devices | 46.67% |
|
Medartis Holding AG
SW:MED |
Medical Devices | 0.00% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
Annual Asset Resilience Ratio for iRhythm Technologies Inc (2015–2025)
The table below shows the annual Asset Resilience Ratio data for iRhythm Technologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 34.09% | $347.75 Million | $1.02 Billion | +21.64pp |
| 2024-12-31 | 12.45% | $115.96 Million | $931.45 Million | -10.08pp |
| 2023-12-31 | 22.53% | $97.59 Million | $433.14 Million | -7.43pp |
| 2022-12-31 | 29.97% | $134.31 Million | $448.22 Million | +5.87pp |
| 2021-12-31 | 24.10% | $111.57 Million | $462.97 Million | -24.09pp |
| 2020-12-31 | 48.19% | $246.59 Million | $511.74 Million | +8.97pp |
| 2019-12-31 | 39.22% | $120.09 Million | $306.21 Million | -9.50pp |
| 2018-12-31 | 48.72% | $58.32 Million | $119.71 Million | -21.66pp |
| 2017-12-31 | 70.38% | $93.69 Million | $133.12 Million | +31.00pp |
| 2016-12-31 | 39.38% | $54.41 Million | $138.16 Million | +39.14pp |
| 2015-12-31 | 0.24% | $91.00K | $37.87 Million | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more